Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems.
The objective is to discuss the strategies for nanocarrier-based co-delivery systems using siRNA/anticancer drug combinations, emphasizing various siRNA targets that help overcome MDR and enhance therapeutic efficiency.
PMID: 28523942 [PubMed - as supplied by publisher]
Source: Drug Development and Industrial Pharmacy - Category: Drugs & Pharmacology Tags: Drug Dev Ind Pharm Source Type: research
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Genetics | Multidrug Resistance | Nanotechnology